# Antimicrobial Principles and Beta-Lactams for NEET PG Pharmacology: WHO AWaRe, ICMR Guidelines, Penicillins, Cephalosporins, Carbapenems

Source: https://tracknation.in/story/antimicrobial-principles-and-beta-lactams-for-neet-pg-pharmacology-who-aware-icmr-guidelines-penicillins-cephalosporins-carbapenems (TrackNation — free UPSC notes with PYQs)

> NEET PG Pharmacology: WHO AWaRe groups and the 60% Access target, India's ICMR antimicrobial guidelines (stewardship, de-escalation, typhoid, cystitis, surgical prophylaxis), penicillins, amoxicillin-clavulanate, benzathine penicillin, ceftriaxone, piperacillin-tazobactam, meropenem, vancomycin, linezolid and colistin, with a diagram, hooks, vignette MCQs and cards.

## Start Here

🎯 **Exam priority: Very high.** *Expect: AWaRe groups, the antibiotic for typhoid in India, surgical prophylaxis timing,
amoxicillin rash in glandular fever, ceftriaxone with calcium, vancomycin infusion reactions and linezolid toxicity.*

CBME mapping: **PH 8.1–8.3**. Indian guidance: **ICMR Treatment Guidelines for Antimicrobial Use in Common Syndromes
(2nd edition, 2019)**; ICMR's 2022 revision was not available to download, so 2019 figures are used.

## WHO AWaRe and Stewardship

*WHO AWaRe groups with examples from the 2023 classification. Drawn by TrackNation.*

- **Access**: narrow spectrum, good safety. **Watch**: broader spectrum; first choice only in more severe
infections or where resistance to Access drugs is likely. **Reserve**: last choice for multidrug-resistant infections.

- WHO target: at least **60%** of national antibiotic use should be Access antibiotics.

- **Stewardship** (ICMR): coordinated measures to improve choice, dose, duration and route; review empirical therapy and
**de-escalate** once cultures return.

## ICMR Choices for Common Syndromes

- **Typhoid**: quinolone resistance up to 69% (S. Typhi) and 23% (S. Paratyphi A); resistance is low to co-trimoxazole,
chloramphenicol and third-generation cephalosporins. Preferred: oral cefixime or azithromycin, or IV ceftriaxone; alternatives (co-trimoxazole,
chloramphenicol, ciprofloxacin) by susceptibility; 10–14 days.

- **Acute cystitis**: nitrofurantoin is the drug of choice.

- **Surgical prophylaxis**: first dose within 1 hour before incision — e.g. a single IV cefazolin 2 g within 60 minutes
before caesarean incision.

## Beta-Lactams and Other Key Drugs

| **Drug (AWaRe group)**

 | **Exam point (label / ICMR)**

 |
| Amoxicillin (Access)

 | Rash in most patients with infectious mononucleosis; contraindicated after serious reaction to any beta-lactam

 |
| Amoxicillin-clavulanate (Access)

 | Contraindicated after Augmentin-associated cholestatic jaundice; pointless if the organism makes no beta-lactamase

 |
| Benzathine penicillin (Access)

 | Deep IM only — never IV; syphilis, yaws; prevents rheumatic fever recurrence

 |
| Cefazolin (Access)

 | Surgical prophylaxis: single 2 g IV dose within 60 minutes before incision (ICMR)

 |
| Ceftriaxone (Watch)

 | Not with calcium-containing IV fluids; contraindicated in premature and hyperbilirubinaemic neonates

 |
| Piperacillin-tazobactam (Watch)

 | Anti-pseudomonal beta-lactam/beta-lactamase inhibitor

 |
| Meropenem (Watch)

 | Lowers valproate levels → breakthrough seizures

 |
| Vancomycin (Watch)

 | Infuse over ≥ 60 minutes (flushing, hypotension if fast); kidney injury; ototoxicity

 |
| Linezolid (Reserve)

 | Weekly blood counts (myelosuppression); serotonin syndrome; tyramine pressor response

 |
| Colistin (Reserve)

 | Perioral numbness and paraesthesia; apnoea/neuromuscular block, worse in renal failure

 |

## Traps the Examiner Sets

- Typhoid in India: not ciprofloxacin first (high resistance) — ceftriaxone, cefixime or azithromycin.

- Prophylactic antibiotic goes in within 60 minutes before the incision, not after.

- Benzathine penicillin given IV can be fatal.

- Meropenem in an epileptic on valproate → seizures.

- Linezolid and colistin are Reserve; vancomycin and carbapenems are Watch.

## Memory Hooks & Shortcuts

*Shortcuts to lock in this article's numbers and lists. Each one only re-packages facts proven above.*

- 🧠 **Traffic light: Green Access, Amber Watch, Red Reserve** — AWaRe colour logic

- 🧠 **Sixty goes Green** — ≥ 60% Access target

- 🧠 **Typhoid: Cipro Can't (69% resistant)** — use ceftriaxone, cefixime or azithromycin

- 🧠 **Cut within the hour** — prophylactic antibiotic ≤ 60 minutes before incision

- 🧠 **Bicillin in a Bottom, never a Bag** — deep IM only, never IV

- 🧠 **Mero Muffles valproate** — seizures from lower valproate levels

- 🧠 **Vanco Very slow (60 min)** — infusion reaction if fast

## Rapid-Revision Cards

- Narrow spectrum, safe: amoxicillin, co-amoxiclav, benzathine penicillin, cefazolin, doxycycline, nitrofurantoin.

- Ceftriaxone, cefixime, azithromycin, ciprofloxacin, pip-tazo, meropenem, vancomycin.

- Colistin, polymyxin B, linezolid, ceftazidime-avibactam, cefiderocol, IV fosfomycin.

- ≥ 60% of national use.

- Right drug, dose, duration, route; de-escalate.

- Quinolones up to 69% (Typhi).

- Cefixime/azithromycin oral, ceftriaxone IV; 10–14 d.

- Nitrofurantoin.

- Cefazolin 2 g IV ≤ 60 min before incision.

- Rash.

- Serious reaction to any β-lactam → avoid amoxicillin.

- Avoid after its cholestatic jaundice.

- Deep IM only; syphilis, yaws, RF prophylaxis.

- No IV calcium; not in premature/jaundiced neonates.

- Valproate ↓ → seizures.

- ≥ 60 min infusion; AKI; ototoxicity.

- Weekly CBC; serotonin syndrome; tyramine.

- Paraesthesia; apnoea in renal failure.

## Sources

*Facts in this article were checked against these documents.*

- Treatment Guidelines for Antimicrobial Use in Common Syndromes, 2nd edition — Indian Council of Medical Research, 2019 (link)

- The WHO AWaRe (Access, Watch, Reserve) antibiotic book — World Health Organization, 2022 (link)

- WHO AWaRe classification of antibiotics, 2023 (EML web annex C) — World Health Organization, 2023 (link)

- Prescribing labels: amoxicillin, Augmentin, Bicillin L-A, ceftriaxone, Zosyn, meropenem, vancomycin, Coly-Mycin M, Zyvox — DailyMed, US National Library of Medicine, current labels, accessed November 2026 (link)

- Competency Based Undergraduate Curriculum, Pharmacology (PH 8.1–8.3) — National Medical Commission, 2024

## Test Yourself: Practice Questions

Twenty-four questions in NEET PG style, most of them clinical vignettes.

## Practice Questions (NEET PG pattern)

*Original questions written in the style of the exam: +4 for a correct answer, −1 for a wrong one. Every answer
was checked against the sources listed above. NEET PG papers are not published by NBEMS, so these are not past-paper questions.*

**Q1.** In the WHO AWaRe classification, amoxicillin belongs to the

- (a) Watch group

- (b) Access group

- (c) Not-recommended group

- (d) Reserve group

**Answer: (b)** — Access: narrow spectrum, good safety.

**Q2.** Ceftriaxone and ciprofloxacin are both in which AWaRe group?

- (a) Reserve

- (b) Not recommended

- (c) Watch

- (d) Access

**Answer: (c)** — Broader spectrum; first choice only in selected situations.

**Q3.** A tertiary hospital uses colistin for carbapenem-resistant Klebsiella. In AWaRe, colistin (IV) is

- (a) Access

- (b) not classified

- (c) Reserve — last resort for multidrug-resistant infections

- (d) Watch

**Answer: (c)** — Also Reserve: polymyxin B, linezolid, ceftazidime-avibactam, cefiderocol.

**Q4.** WHO's national target for antibiotic consumption is that at least

- (a) 60% should be Watch antibiotics

- (b) 10% should be Reserve

- (c) 60% should be Access antibiotics

- (d) 90% should be Reserve

**Answer: (c)** — WHO AWaRe book.

**Q5.** A 22-year-old in Delhi has blood-culture-proven typhoid. Given ICMR's resistance data, a preferred drug is

- (a) ciprofloxacin empirically

- (b) penicillin G

- (c) ceftriaxone (or oral cefixime/azithromycin)

- (d) nitrofurantoin

**Answer: (c)** — Quinolone resistance up to 69% for S. Typhi; ICMR prefers cefixime or azithromycin orally, ceftriaxone IV; 10–14 days.

**Q6.** ICMR's recommended duration of antibiotic treatment for typhoid is

- (a) 6 weeks

- (b) single dose

- (c) 3 days

- (d) 10–14 days

**Answer: (d)** — ICMR 2019 Table 2.1.

**Q7.** A non-pregnant woman has uncomplicated acute cystitis. ICMR's drug of choice is

- (a) ceftriaxone

- (b) nitrofurantoin

- (c) meropenem

- (d) colistin

**Answer: (b)** — Nitrofurantoin is also an Access antibiotic.

**Q8.** For an elective caesarean section, ICMR's antibiotic prophylaxis is

- (a) ceftriaxone for 7 days after surgery

- (b) a single IV dose of cefazolin 2 g within 60 minutes before incision

- (c) meropenem at skin closure

- (d) no antibiotic

**Answer: (b)** — First dose within one hour before incision.

**Q9.** Reviewing a patient on empirical meropenem whose culture grows a sensitive organism, the stewardship action is to

- (a) continue meropenem for 6 weeks

- (b) add colistin

- (c) stop all antibiotics today regardless

- (d) de-escalate to a narrower drug

**Answer: (d)** — ICMR: evaluate whether empirical therapy can be justified or de-escalated.

**Q10.** A teenager with infectious mononucleosis is given amoxicillin and develops a widespread red rash. The explanation is

- (a) scarlet fever

- (b) true penicillin allergy for life

- (c) Stevens-Johnson syndrome

- (d) most patients with mononucleosis given amoxicillin develop a rash

**Answer: (d)** — Amoxicillin label.

**Q11.** A patient had anaphylaxis to a cephalosporin. Amoxicillin is

- (a) preferred

- (b) safe if given IV

- (c) safe

- (d) contraindicated (serious reaction to another beta-lactam)

**Answer: (d)** — Label contraindication.

**Q12.** A man developed cholestatic jaundice during a previous course of amoxicillin-clavulanate. Now

- (a) give it IV

- (b) only reduce the dose

- (c) Augmentin is contraindicated

- (d) it is safe to repeat

**Answer: (c)** — Contraindication.

**Q13.** Benzathine penicillin for secondary prophylaxis of rheumatic fever must be given

- (a) IV push

- (b) orally

- (c) by deep IM injection only — never IV

- (d) subcutaneously

**Answer: (c)** — Bicillin L-A boxed statement; also for syphilis and yaws.

**Q14.** A neonatal unit plans ceftriaxone with calcium-containing IV fluids in a jaundiced premature baby. The label says

- (a) safe

- (b) contraindicated: risk of ceftriaxone-calcium precipitation; avoid in premature/hyperbilirubinaemic neonates

- (c) only reduce the dose

- (d) give with extra calcium

**Answer: (b)** — Ceftriaxone label.

**Q15.** An epileptic on valproate gets meropenem for sepsis and starts having seizures. The cause is

- (a) valproate toxicity

- (b) meropenem raising valproate levels

- (c) meropenem lowering valproate levels

- (d) hyponatraemia only

**Answer: (c)** — Breakthrough seizures from reduced valproic acid concentrations.

**Q16.** During a rapid vancomycin infusion a patient becomes flushed, itchy and hypotensive. The fix is

- (a) add calcium

- (b) give it as a bolus

- (c) infuse over at least 60 minutes

- (d) switch to oral route for sepsis

**Answer: (c)** — Infusion reaction; also watch kidney injury and ototoxicity.

**Q17.** A patient on vancomycin and an aminoglycoside develops rising creatinine. The label warns that vancomycin

- (a) only causes rash

- (b) causes hypoglycaemia

- (c) protects the kidneys

- (d) can cause acute kidney injury, more with other nephrotoxins

**Answer: (d)** — Risk rises with exposure.

**Q18.** A man on linezolid for 3 weeks develops thrombocytopenia. The label advises

- (a) doubling the dose

- (b) adding an SSRI

- (c) no monitoring

- (d) weekly complete blood counts (myelosuppression)

**Answer: (d)** — Also serotonin syndrome and a tyramine pressor response.

**Q19.** A patient on linezolid eats aged cheese and develops a severe headache with high BP. The mechanism is

- (a) renal failure

- (b) allergy

- (c) hypoglycaemia

- (d) linezolid's MAO-inhibiting pressor response with tyramine

**Answer: (d)** — Label: significant pressor response with linezolid plus tyramine.

**Q20.** A patient with renal failure on colistin develops perioral numbness and then breathing difficulty. The concern is

- (a) hepatitis

- (b) neuromuscular blockade and apnoea, more likely in renal impairment

- (c) hypercalcaemia

- (d) anaphylaxis to penicillin

**Answer: (b)** — Coly-Mycin M label.

**Q21.** Augmentin should not be used when culture shows

- (a) the organism is amoxicillin-sensitive (no beta-lactamase)

- (b) mixed infection

- (c) beta-lactamase production

- (d) H. influenzae resistance

**Answer: (a)** — Clavulanate adds nothing without beta-lactamase.

**Q22.** Benzathine penicillin is labelled for the treatment of

- (a) typhoid

- (b) malaria

- (c) tuberculosis

- (d) syphilis and yaws

**Answer: (d)** — Also prevents recurrence of rheumatic fever and chorea.

**Q23.** Which antibiotic is an AWaRe Access drug and the ICMR choice for surgical prophylaxis?

- (a) Cefazolin

- (b) Meropenem

- (c) Linezolid

- (d) Colistin

**Answer: (a)** — First-generation cephalosporin.

**Q24.** ICMR defines antimicrobial stewardship as

- (a) banning all antibiotics

- (b) coordinated interventions to measure and improve appropriate antibiotic use

- (c) giving antibiotics for all fevers

- (d) using only Reserve antibiotics

**Answer: (b)** — Optimal choice, dose, duration and route.

### Active Recall

From memory: define the three WHO AWaRe groups with examples and the Access target; explain stewardship and de-escalation; give ICMR's choices for typhoid, acute cystitis and surgical prophylaxis; and give the key warning for amoxicillin, co-amoxiclav, benzathine penicillin, ceftriaxone, meropenem, vancomycin, linezolid and colistin.
